system
Medical AI Inquiry: You were designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.
user
Which of the following DPP IV inhibitors does not require dose modification in Chronic kidney disease patients
assistant
The correct answer is  Linagliptin is is DPP IV inhibitors does not require dose modifications in Chronic kidney disease patients and can be used even in stage 5 ckd patients .